합성생물학 시장은 2021년 105억4416만 달러에서 2028년 378억5085만 달러로 성장할 것으로 예상된다. 2021년부터 2028년까지 연평균 20.0% 성장할 것으로 예상됩니다.
의료 합성 생물학은 특정 치료 또는 산업 유틸리티. 생성된 유기체는 유전적으로 변형된 유기체(GMO)이며, 이를 유전자 변형과 구별하는 정의가 필요하지 않습니다. 합성 생물학 시장의 성장은 투자 증가, 기술 발전 및 신생 기업의 증가에 기인합니다. 또한, 합성 생물학의 새로운 트렌드는 향후 시장 성장에 긍정적인 영향을 미칠 가능성이 높습니다.
전략적 통찰력
합성 생물학 시장은 제품, 기술, 응용 및 지역으로 구분됩니다. 지리적으로 시장은 북미, 유럽, 아시아 태평양, 중동 및 아프리카, 중남미로 광범위하게 분류됩니다. 합성 생물학 시장 보고서는 시장 동향, 기술 발전, 시장 역학 및 전 세계 주요 시장 참가자의 경쟁 분석을 강조하여 시장에 대한 통찰력과 심층 분석을 제공합니다.
합성 생물학 시장의 수익성 있는 지역
시장 통찰력 합성 생물학에 대한 투자 증가가 합성 생물학 시장 주도
합성 생물학은 새로운 개념으로 화학, 농업, 제약 및 에너지 산업에 수많은 응용 분야가 있습니다. 다양한 스타트업이 생물학적 공정을 위한 유전자 합성 제품/서비스를 제공합니다. 예를 들어, Benchling은 CAD 도구를 제공하고, GenScript는 유전자 합성을 제공하고, Ginkgo Bioworks는 유기체 공학을 지원하고, Transcripts(생물 정보학 회사)는 클라우드 실험실/자동화를 촉진하는 솔루션을 제공하고 Glowee는 소비자 제품을 제공합니다. 또한, 2020년 상반기에 56개 합성 생물학 기업이 30억 달러 이상의 주식 자금 조달을 통해 2020년 같은 기간에 65개 기업이 19억 달러를 모금했습니다. 차세대 바이오 제약 비즈니스는 합성 생물학을 사용하여 세포 치료 및 유전자 치료 및 조기 암 발견을 지원합니다. 2020년 상반기에 가장 많은 자금을 조달한 일부 합성 생물학 회사는 다음과 같습니다.
2020년 상반기에 가장 많은 자금을 조달한 합성 생물학 회사
< TIP>
제품 통찰력
제품을 기준으로 글로벌 합성 생물학 시장은 올리고뉴클레오티드, 새시 유기체, 효소 및 이종 핵산으로 분류됩니다. 올리고뉴클레오티드 세그먼트는 2021년에 시장에서 가장 큰 점유율을 차지했습니다. 또한, 동일한 세그먼트는 2021년에서 2028년까지의 예측 기간 동안 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다. 이는 주로 유전자 검사에서 올리고뉴클레오티드의 적용이 증가하고 있기 때문입니다. / 분석 및 법의학.
합성 생물학 시장, 제품별(2021-2028)
기술 통찰력
< TIP>글로벌 합성생물학 시장은 기술을 기반으로 유전자 합성, 게놈 공학, 측정 및 모델링, 클로닝 및 시퀀싱, 나노기술 등으로 세분화됩니다. 2021년에는 유전자 합성 부문이 시장에서 가장 큰 점유율을 차지할 것으로 보입니다. 그러나 게놈 공학 부문은 2021년부터 2028년까지 가장 높은 CAGR을 기록할 것으로 예상됩니다. 게놈 공학 부문의 성장은 유전 공학 및 유전자 치료의 응용이 증가하고 있기 때문입니다.
Application Insights
응용 프로그램을 기반으로 글로벌 합성 생물학 시장은 의료 응용, 산업 응용, 환경 응용, 식품으로 분류됩니다. 농업 및 기타. 의료 응용 부문은 약물 발견 및 치료제 및 의약품으로 세분화됩니다. 2021년에는 의료 애플리케이션 부문이 가장 큰 시장 점유율을 차지했으며 2021-2028년 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.
제품 출시 및 협업은 글로벌 합성 생물학 시장 참가자들이 많이 채택하는 전략입니다. 최근 주요 시장 개발 중 일부는 다음과 같습니다.
- 2022년 2월 Thermo Fisher Scientific은 유연한 유전형 분석 소프트웨어 패키지인 GeneMapper Software의 출시를 발표했습니다. 모든 Thermo Fisher Scientific 전기영동 기반 유전형 분석에 대한 DNA 크기 및 품질 대립유전자 호출을 제공합니다.
- 2022년 1월 Thermo Fisher Scientific은 Oncomine BRCA Assay GX 출시를 발표했습니다. 인간 BRCA1 및 BRCA2 유전자의 모든 코딩 영역을 포괄적으로 증폭하여 다양한 돌연변이 클래스를 정확하고 민감하게 검출할 수 있도록 설계된 표적 차세대 시퀀싱(NGS) 분석입니다.
- In 2022년 4월, Merck KGaA는 선도적인 자동 바이오리액터 샘플링 시스템인 Lonza의 MAST 플랫폼을 인수했습니다. MAST 플랫폼의 인수는 Mercks 프로세스 솔루션 사업부의 혁신을 가속화하는 또 다른 이정표입니다.
- 2022년 2월 Merck는 규제 승인 및 기타 조건 충족에 따라 Exalead 인수 거래를 종료한다고 발표했습니다. 약 7억 8천만 달러의 현금으로 관례적인 폐쇄 조건을 체결했습니다.
COVID-19 팬데믹으로 인해 글로벌 합성 생물학 시장의 많은 기업들이 사업을 중단해야 했습니다. 질병의 확산을 통제하기 위한 새로운 정부 규정을 따르기 위한 단기 운영. 이러한 운영 중단은 글로벌 합성 생물학 시장의 수익 흐름에 직접적인 영향을 미쳤습니다. 또한 봉쇄 기간 동안 원자재와 인력이 부족해 공산품 생산이 중단됐다. 또한 이 부문에서 활동하는 회사에 새로운 위탁을 받지 않았습니다. 따라서 몇 개월 간의 산업 활동 중단과 봉쇄는 글로벌 합성 생물학 산업에 영향을 미쳤습니다. COVID-19 발병은 국가의 폐쇄 조치와 제약 및 생명 공학 회사에서 사용되는 원료, 공정 재료 및 중간 제품의 제조 및 생산 지연으로 인해 합성 생물학 산업의 성장에 영향을 미쳤습니다. 시장은 예측 기간 동안 더딘 회복세를 보일 것으로 예상됩니다.
합성 생물학 - 시장 세분화
글로벌 합성 생물학 시장 제품, 기술 응용 프로그램 및 지역을 기준으로 세분화됩니다. 제품을 기준으로 시장은 올리고뉴클레오티드, 새시 유기체, 효소 및 이종 핵산으로 분류됩니다. 기술을 기반으로 합성 생물학 시장은 유전자 합성, 게놈 공학, 측정 및 모델링, 클로닝 및 시퀀싱, 나노 기술 등으로 분류됩니다. 애플리케이션을 기반으로 합성 생물학 시장은 의료 애플리케이션, 산업 애플리케이션, 환경 애플리케이션, 식품 및 농업 등으로 분류됩니다. 지리적으로 합성 생물학 시장은 북미, 유럽, 아시아 태평양, 중동 및 아프리카, 중남미로 분류됩니다.
회사 프로필
- THERMO FISHER SCIENTIFIC INC.
- 애질런트 Technologies, Inc.
- MERCK KGaA
- New England Biolabs
- 통합 DNA 기술
- GenScript Biotech Corporation
- Novozymes A/S
- Codexis
< li>Twist Bioscience
< li>Amyris Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
As per application, the medical applications segment is accounted to grow at the fastest CAGR in the market during the forecast period.
The synthetic biology market majorly consists of the players such as Thermo Fisher Scientific
Agilent technologies; Merck KGaA; New England Biolabs; Integrated DNA Technologies; Twists Bioscience; Genscript Biotech corporation; Novozymes A/S; Codexis; Amyris among others.
The oligonucleotides segment held the largest revenue share in 2021.
Synthetic biology is a science of designing, altering and building simple organisms to perform specific therapeutic or industrial utilities. The commercialization or industrialization of biology renders processes quicker, cheaper and reliable. The organisms created are known as genetically modified organisms (GMOs), which do not require a definition that distinguishes it from genetic modifications.
The List of Companies - Synthetic Biology Market
- Thermo Fisher Scientific
- Agilent technologies
- Merck KGaA
- New England Biolabs
- Integrated DNA Technologies
- Twists Bioscience
- Genscript Biotech corporation
- Novozymes A/S
- Codexis
- Amyris
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2022
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2022
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2022
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2022
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2022
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2022
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)